IPRIPR2017-01648Final Written Decision
Aurobindo Pharma USA Inc. et al.v.Andrx Labs, LLC et al.
IPR challenge of US 6866866.
Type
IPR
Filed
Jun 22, 2017
Instituted
Dec 29, 2017
Decided
—
Patent
Application
09705630
Inventor
—
Granted
Mar 15, 2005
01
Timeline
3 milestones
2017-06-22Petition filed
2017-12-29Institution
2018-12-28Terminated
02
Parties & counsel
Petitioner
Aurobindo Pharma USA Inc. et al.
Counsel
Moore, Stevenet al
Patent Owner
Andrx Labs, LLC et al.
Counsel
Cavanaugh, Davidet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →